342 related articles for article (PubMed ID: 17329288)
1. The Open Field Test: reinventing the wheel.
Stanford SC
J Psychopharmacol; 2007 Mar; 21(2):134-5. PubMed ID: 17329288
[No Abstract] [Full Text] [Related]
2. The Open Field Test for two.
Overstreet DH
J Psychopharmacol; 2007 Mar; 21(2):140. PubMed ID: 17329290
[No Abstract] [Full Text] [Related]
3. Open fields (unlike wheels) can be any shape but still miss the target.
Stanford SC
J Psychopharmacol; 2007 Mar; 21(2):144. PubMed ID: 17329292
[No Abstract] [Full Text] [Related]
4. More haste, considerably less speed.
Rodgers RJ
J Psychopharmacol; 2007 Mar; 21(2):141-3. PubMed ID: 17329291
[No Abstract] [Full Text] [Related]
5. Test standardization in behavioural neuroscience: a response to Stanford.
Blizard DA; Takahashi A; Galsworthy MJ; Martin B; Koide T
J Psychopharmacol; 2007 Mar; 21(2):136-9. PubMed ID: 17329289
[No Abstract] [Full Text] [Related]
6. New screening tools for lead compound identification.
Sawyer TK
Nat Chem Biol; 2005 Aug; 1(3):125. PubMed ID: 16408012
[No Abstract] [Full Text] [Related]
7. Reference ranges for screening preclinical drug safety data.
Amaratunga D
J Biopharm Stat; 1997 Jul; 7(3):417-22. PubMed ID: 9252834
[TBL] [Abstract][Full Text] [Related]
8. Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals.
Claude JR; Claude N
Toxicol Lett; 2004 Jun; 151(1):25-8. PubMed ID: 15177637
[TBL] [Abstract][Full Text] [Related]
9. [Methodological problems of studying the pharmacology of the kidneys].
Berkhin EB
Farmakol Toksikol; 1979; 42(4):339-46. PubMed ID: 383500
[No Abstract] [Full Text] [Related]
10. Use and abuse of QT and TRIaD in cardiac safety research: importance of study design and conduct.
Hondeghem LM
Eur J Pharmacol; 2008 Apr; 584(1):1-9. PubMed ID: 18304526
[TBL] [Abstract][Full Text] [Related]
11. [Methodological characteristics of the preclinical study of the safety of drug preparations for children].
Mal'tseva LF; Muratova GP; Motovilova VG; Sirinova NA
Farmakol Toksikol; 1988; 51(4):96-100. PubMed ID: 3191987
[TBL] [Abstract][Full Text] [Related]
12. [Problems in preclinical pharmacology when deciding on suitable animal species and animal tests models].
Hoefke W
Arzneimittelforschung; 1977 Feb; 27(2A):223-8. PubMed ID: 577167
[TBL] [Abstract][Full Text] [Related]
13. [The current requirements for the preclinical study of the safety of new drugs].
Arzamastsev EV; Liubimov BI
Eksp Klin Farmakol; 1995; 58(3):7-12. PubMed ID: 7663306
[No Abstract] [Full Text] [Related]
14. A comparison of two variants of the chimney behaviour test in mice.
Heinecke H
Z Versuchstierkd; 1987; 29(3-4):145-8. PubMed ID: 3617967
[No Abstract] [Full Text] [Related]
15. Evaluations of organ system development in juvenile toxicology testing.
Robinson K
Reprod Toxicol; 2008 Sep; 26(1):51-3. PubMed ID: 18595655
[TBL] [Abstract][Full Text] [Related]
16. Safety evaluation to support First-In-Man investigations I: kinetic and safety pharmacology studies.
Baldrick P
Regul Toxicol Pharmacol; 2008 Jul; 51(2):230-6. PubMed ID: 18501489
[TBL] [Abstract][Full Text] [Related]
17. Animals and animal tissues in the discipline of pharmacology.
Simpson LL
Ann N Y Acad Sci; 1983; 406():74-81. PubMed ID: 6349467
[No Abstract] [Full Text] [Related]
18. Evaluation of acute bis(7)-tacrine treatment on behavioral functions in 17-day-old and 30-day-old mice, with attention to drug toxicity.
Pan SY; Yu ZL; Dong H; Lee NT; Wang H; Fong WF; Han YF; Ko KM
Pharmacol Biochem Behav; 2007 Apr; 86(4):778-83. PubMed ID: 17449090
[TBL] [Abstract][Full Text] [Related]
19. The debate on animal ADME studies in drug development: an update.
Pellegatti M
Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1615-20. PubMed ID: 25373428
[TBL] [Abstract][Full Text] [Related]
20. The muddle of models: what you don't know can hurt you.
Robertson DG
Chem Res Toxicol; 2008 Oct; 21(10):1917-22. PubMed ID: 18729325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
